# LORATADINE
> **ANDA219223** · Abbreviated New Drug Application (Generic) · Sponsor: MARKSANS PHARMA · Approved 2024-11-21
## Drug
- **FDA Application Number:** ANDA219223
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LORATADINE
- **Generic name:** LORATADINE TABLETS USP, 10 MG
- **Active ingredients:** LORATADINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** MARKSANS PHARMA
- **Manufacturer:** TIME CAP LABORATORIES, INC.
- **First approval:** 2024-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219223)
---
*AI Analytics · CC0 1.0*